2005Unpublished venueRequires access

Effectiveness of olanzapine in treatment of schizophrenia

LI Yan-cha

Open publisher page 3 citations

Abstract

Objective:To explore the efficacy and safety of olanzapine in the treatment of schizophrenia. Method:123 cases with schizophrenia were randomly divided into olanzapine group(n=61) or clozapine group(n=62).Positive and negative symptoms scale (PANSS) and treatment emergant symptom scale (TESS) were used to measure the efficacy and safety before treatment and at the end of 1st,2nd,4th,6th and 8th week treatment respectively. Results:There were no significant differences in effectiveness between two groups. However, significant differences were found between two groups in the reduction rates of scales about cognitive factors and negative symptoms. Conclusion:The study suggests that olanzapine is a safe and effective agent in the treatment of schizophrenia.

About this research paper

What this paper is about

Objective:To explore the efficacy and safety of olanzapine in the treatment of schizophrenia. Method:123 cases with schizophrenia were randomly divided into olanzapine group(n=61) or clozapine group(n=62).Positive and negative symptoms scale (PANSS) and treatment emergant symptom scale (TESS) were used to measure the efficacy and safety before treatment and at the end of 1st,2nd,4th,6th and 8th week treatment respectively. Results:There were no significant differences in effectiveness between two groups. However, significant differences were found between two groups in the reduction rates of scales about cognitive factors and negative symptoms. Conclusion:The study suggests that olanzapine is a safe and effective agent in the treatment of schizophrenia.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To explore the efficacy and safety of olanzapine in the treatment of schizophrenia. Method:123 cases with schizophrenia were randomly divided into olanzapine group(n=61) or clozapine group(n=62).Positive and negative symptoms scale (PANSS) and treatment emergant symptom scale (TESS) were used to measure the efficacy and safety before treatment and at the end of 1st,2nd,4th,6th and 8th week treatment respectively. Results:There were no significant differences in effectiveness between two groups. However, significant differences were found between two groups in the reduction rates of scales about cognitive factors and negative symptoms. Conclusion:The study suggests that olanzapine is a safe and effective agent in the treatment of schizophrenia.

Key concepts: Olanzapine, Schizophrenia (object-oriented programming), Clozapine, Negative symptom, Psychology, Psychiatry, Internal medicine, Clinical psychology

Related papers

Back to paper searchBrowse research topicsOriginal source
Effectiveness of olanzapine in treatment of schizophrenia — Research Paper | ScholarLens